”Our journey with EPS started with Engage Therapeutics, a clinical stage company developing a novel seizure termination product through a large phase 2b trial. We turned to EPS to help with recruitment of this important new product for the Epilepsy community. Together we built a recruiting website, built brand awareness, and created unique marketing materials to get the study enrolled in a calendar year. After Engage was acquired, in a new venture called Reunion Neuroscience we turned to EPS again. This time the company is investigating a novel psychedelic compound for the treatment of Post Partum Depression.
EPS played a critical role in helping us achieve our objectives by bringing marketing expertise and ability to be nimble and respond with urgency. The EPS team responds quickly no matter how large or small the task and always does so with energy and passion. EPS has been a great partner in our last venture as well as our current one and would expect that this is only the beginning. Good people wanting the do the right things coming up with creative ideas while being cost effective is an unusual combination which is why we have consistently turned to Rick and the team as partners to help enroll our clinical programs.
Mark TheeuwesChief Operating Officer, Reunion Neuroscience
